COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 1484: Articles 14831-14840  | Next

ASSESSMENT OF PERFORMANCE AND IMPLEMENTATION CHARACTERISTICS OF RAPID POINT OF CARE SARS-CoV-2 ANTIGEN TESTING IN KENYA
Gitaka, J., Muthamia, E., Mbugua, S., Mungai, M., Bandawe, G., Qadri, F., Kawser, Z., Lockman, S., Ivers, L., Walt, D. R., Suliman, S., Mwau, M.
10.1101/2021.06.03.21258290 — Posted: 2021-06-06
Inferring SARS-CoV-2 RNA shedding into wastewater relative to time of infection
Cavany, S. M., Bivins, A., Wu, Z., North, D., Bibby, K., Perkins, A.
10.1101/2021.06.03.21258238 — Posted: 2021-06-06
Virtual care and the impact of COVID-19 on nursing: A single centre evaluation
Hughes, L., Petrella, A., Phillips, N., Taylor, R. M.
10.1101/2021.06.03.21258276 — Posted: 2021-06-05
Transmission of SARS-CoV-2 associated with aircraft travel: a systematic review (Version 1)
Rosca, E. C., Heneghan, C., Spencer, E. A., Brassey, J., Pluddemann, A., Onakpoya, I., Evans, D. H., Conly, J. M., Jefferson, T.
10.1101/2021.06.03.21258274 — Posted: 2021-06-05
Clinical performance of two EUA-approved anti-COVID-19 IgG/IgM rapid lateral flow immunoassays using whole blood finger-sticks
Tagwerker, C., Baig, I., Brunson, E., Mundo, K., Dutra-Smith, D., Carias-Marines, M. J., de Zoysa, R. S., Smith, D. J.
10.1101/2021.06.04.21258189 — Posted: 2021-06-05
Direct comparison of venipuncture serum draws versus whole blood finger-stick specimens by anti-COVID-19 IgG/IgM rapid lateral flow immunoassay and ELISA.
Baig, I., Tagwerker, C., Brunson, E. J., Mundo, K., Dutra-Smith, D., Carias, M. J., de Zoysa, R. S., Smith, D. J.
10.1101/2021.06.04.21258182 — Posted: 2021-06-05
Multisystemic cellular tropism of SARS-CoV-2 in autopsies of COVID-19 patients
Wong, D. W. L., Klinkhammer, B. M., Djudjaj, S., Villwock, S., Timm, M. C., Buhl, E. M., Wucherpfennig, S., Cacchi, C., Braunschweig, T., Knüchel-Clarke, R., Jonigk, D., Werlein, C., Bülow, R. D., Dahl, E., von Stillfried, S., Boor, P.
10.1101/2021.06.03.21258241 — Posted: 2021-06-05
Vaccine nationalism and the dynamics and control of SARS-CoV-2
Wagner, C. E., Saad-Roy, C. M., Morris, S. E., Baker, R. E., Mina, M. J., Farrar, J., Holmes, E. C., Pybus, O. G., Graham, A. L., Emanuel, E. J., Levin, S. A., Metcalf, C. J. E., Grenfell, B. T.
10.1101/2021.06.02.21258229 — Posted: 2021-06-05
Group Testing Large Populations for SARS-CoV-2
Zabeti, H., Dexter, N., Lau, I., Unruh, L., Adcock, B., Chindelevitch, L.
10.1101/2021.06.03.21258258 — Posted: 2021-06-05
Effectiveness of mRNA COVID-19 Vaccines among Employees in an American Healthcare System
Shrestha, N. K., Nowacki, A. S., Burke, P. C., Terpeluk, P., Gordon, S. M.
10.1101/2021.06.02.21258231 — Posted: 2021-06-05 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).